Results 171 to 180 of about 142,764 (336)

Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction [PDF]

, 1988
Pere Ginès, Wladimiro Jiménez, Vicente Arroyo, Miquel Navasa, Clara López, Lluçia Titó, Antoni Serra, Jaime Bosch, G Sánz, Francisca Rivera, Joan Rodés   +10 more
openalex   +1 more source

In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

Proceedings of the National Academy of Sciences of the United States of America, 1986
Chou-Long Huang, H. Ives, M. G. Cogan
semanticscholar   +1 more source

Cost‐Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi‐Experimental Study

Journal of Cardiovascular Electrophysiology, EarlyView.
Cost‐utility of LBBAP CRT versus BVP CRT. ABSTRACT Introduction Cardiac resynchronization therapy (CRT) is a well‐established treatment for patients with heart failure (HF). Recently, left bundle branch area pacing (LBBAP) has emerged as a more physiological alternative to biventricular pacing (BVP) for CRT.
José M. Sánchez‐Moreno, Leticia García‐Mochón, Manuel Molina‐Lerma, Guillermo Gutiérrez‐Ballesteros, Manuel Frutos‐López, Ricardo Pavón‐Jiménez, M. C. Olvera‐Porcel, Juan Jiménez‐Jáimez, Miguel Álvarez   +8 more
wiley   +1 more source

NT‐proBNP With Postoperative Complications and 2‐Year Mortality Among Hip Fracture Patients: An Observational Cohort Study

Orthopaedic Surgery, EarlyView.
Preoperative NT‐proBNP is strongly associated with both postoperative complications and 2‐year all‐cause mortality among patients who received hip fracture surgery. Higher levels of NT‐proBNP before surgery may serve as a useful biomarker for risk stratification and guiding treatment decisions for this patient subpopulation.
Xisheng Lin, Yu Jiang, Yilin Wang, Shuhuai Tan, Xiang Cui, Yan Luo, Houchen Lyu, Licheng Zhang, Peifu Tang   +8 more
wiley   +1 more source

Anantin-A peptide antagonist of the atrial natriuretic factor(ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.

, 1991
Daniel F. Wyss, H W Lahm, Michael Manneberg, Alexander M. Labhardt   +3 more
openalex   +2 more sources

Chronic Elevation of Calmodulin in the Ventricles of Transgenic Mice Increases the Autonomous Activity of Calmodulin-Dependent Protein Kinase II, Which Regulates Atrial Natriuretic Factor Gene Expression [PDF]

, 2000
Josep M. Colomer, Anthony R. Means
openalex   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar, Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Mischa T. Rijnierse, Michiel J. B. Kemme, Cornelis P. Allaart, Vokko P. van Halm   +6 more
wiley   +1 more source

Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac atrial natriuretic factor gene transcription.

, 1991
S Argentin, Yu Sun, Isabelle Lihrmann, Thomas J. Schmidt, Jacques Drouin, Mona Nemer   +5 more
openalex   +1 more source

Friend of GATA 2 Physically Interacts with Chicken Ovalbumin Upstream Promoter-TF2 (COUP-TF2) and COUP-TF3 and Represses COUP-TF2-dependent Activation of the Atrial Natriuretic Factor Promoter [PDF]

, 2001
Gordon S. Huggins, Christopher J. Bacani, Jay Boltax, Ryuichi Aikawa, Jeffrey M. Leiden   +4 more
openalex   +1 more source

Establishment of a mouse model for ischaemic heart failure induced by coronary microembolization via left ventricular oil injection

Experimental Physiology, EarlyView.
Abstract Over the past three decades, there has been a steady increase in clinical attention to ischaemic heart failure caused by coronary microembolization. Nonetheless, a suitable mouse model for studying this condition remains limited. In the present study, we developed a mouse model of coronary microembolization‐induced ischaemic heart failure by ...
Lang Pei, Yusheng Hong, Qiuyue Wu, Jianyi Lv, Changlong Li, Xueyun Huo, Xin Liu, Di Zhang, Meng Guo, Zhenwen Chen, Xiaoyan Du   +10 more
wiley   +1 more source